Adeline Pharma Private Limited
About Adeline Pharma Private Limited
Data last updated:
Adeline Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Keimed Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 May 2016.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24200TS2016PTC172691. Its GSTIN is 19AAOCA3402D1ZZ (West Bengal). The company held 2 GST registrations, all of them active.
The company had an authorised share capital of ₹5 Cr and a paid-up capital of ₹2 Cr. It was led by directors including Desmond Kajal Gomes (Managing Director) and Pearl Gloria Gomes.
Its last annual general meeting (AGM) was held on 06 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹221.13 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.16 Cr (net margin 1.4%) and EBITDA of ₹7.55 Cr (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 11% over five years.
The company had about 52 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Adeline Pharma. As per MCA filings, the company had satisfied charges of ₹84 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending. The company has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹16.5 Lakh; the latest was in June 2016. Its 8 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 4 smaller; the largest is Tancom Electronics Private Limited with revenue of ₹230.72 Cr.
Company details
CIN history
Adeline Pharma has one previous CIN (Corporate Identification Number): U24200WB2016PTC215615. The current CIN is U24200TS2016PTC172691, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24200TS2016PTC172691 | Current |
| U24200WB2016PTC215615 | Previous |
Contact details
Adeline Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShe No – 2 7 – 2 – 1740 Fire Station Main Road, Sanathnagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Adeline Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Adeline Pharma operates one associated brand: Adeline Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supply of pharmaceutical products including oncology, gynecology, and rheumatology in India. | adelinepharma.in |
Business activity
The main business activity of Adeline Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adeline Pharma Private Limited, buy the company report.
Financials of Adeline Pharma Private Limited
FY 2023 filings availableAdeline Pharma Private Limited reported revenue of ₹221.13 Cr (down 6% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adeline Pharma Private Limited, buy the company report.
Board of directors of Adeline Pharma Private Limited
Adeline Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 24 Jun 2016 | 10 Years 4 Months | As last reported |
| Pearl Gloria Gomes Also directs: Adeline Pharmaceuticals Private Limited | Director | 03 May 2016 | 10 Years 5 Months | As last reported |
| Desmond Kajal Gomes Also directs: Adeline Pharmaceuticals Private Limited | Managing Director | 03 May 2016 | 10 Years 5 Months | As last reported |
Peer comparison
Adeline Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tancom Electronics Private Limited | ₹230.72 Cr (FY 2025) | 84.0% | Mumbai, Maharashtra, India | |||
| Getwell Medicare Solution Private Limited | ₹225.29 Cr (FY 2025) | 23.0% | Ernakulam, Kerala, India | |||
| Pharmapoint (India) Private Limited | ₹222.83 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India | |||
| Workcell Solutions Private Limited | ₹221.81 Cr (FY 2025) | 46.0% | Mumbai, Maharashtra, India | |||
| Adeline Pharma Private Limitedthis company | ₹221.13 Cr (FY 2023) | ₹3.16 Cr | 1.4% | -6.0% | 52 | Hyderabad, Telangana, India |
| D Vijay Pharma Private Limited | ₹219.42 Cr (FY 2025) | 23.0% | Nashik, Maharashtra, India | |||
| Alteus Biogenics Private Limited | ₹217.9 Cr (FY 2025) | 27.0% | Kolkata, West Bengal, India | |||
| Vasu Vaccines and Speciality Drugs Hyd Private Limited | ₹215.31 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Shreeji Distributors Pharma Private Limited | ₹214.34 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Adeline Pharma Private Limited, buy the company report.
Auditor
Adeline Pharma Private Limited is audited by PAL & ROY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAL & ROY | FY 2022 | 302210E |
Shareholding
The shareholding of Adeline Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Adeline Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Mar 2021 | 100423975 | Hdfc Bank Limited | ₹33 Cr | Satisfied | |
| 08 Feb 2019 | 100243695 | Others | ₹28 Cr | Satisfied | |
| 27 Jun 2016 | 100087621 | Hdfc Bank Limited | ₹23 Cr | Satisfied |
To see the full charge records of Adeline Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Adeline Pharma Private Limited has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹16.5 Lakh; the latest was in June 2016.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2016 | Funding round | ₹16.5 Lakh | Investors: 2 individuals |
| Jun 2016 | Acquisition | ₹13.78 Cr | Buyer: Keimed Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Adeline Pharma Private Limited has 4 court cases on record: 4 filed by Adeline Pharma. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
| NCLT | 2 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company against Keimed Private Limited | Disposed |
| District court, Darjeeling, West Bengal | Civil suit | Filed by the company against M/S Creation Pharma | Pending |
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed by the company against individuals | Disposed |
To see the full case history of Adeline Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Adeline Pharma Private Limited was last rated by Care on 05 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 05 Oct 2021 |
To see the full credit ratings and regulatory alerts of Adeline Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adeline Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Adeline Pharma Private Limited has a workforce of 52 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.
GST
Adeline Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAOCA3402D1ZZ | West Bengal | Active | 01 Jul 2017 |
| 21AAOCA3402D1ZE | Odisha | Active | 08 Jul 2019 |
To see the full GST registrations and return filing status of Adeline Pharma Private Limited, buy the company report.
Recent activity
Adeline Pharma Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Arvind Kumar Venkat ceased to be Director on 26 Jun 2019.
5 earlier events are in the company report.
Frequently asked questions
Adeline Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Adeline Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 May 2016 and is registered under CIN U24200TS2016PTC172691. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Adeline Pharma was incorporated on 03 May 2016. It is registered with the Registrar of Companies, Hyderabad.
Adeline Pharma had 3 directors:
- Desmond Kajal Gomes - Managing Director
- Arvind Kumar Venkat - Nominee Director
- Pearl Gloria Gomes - Director
The CIN (Corporate Identification Number) of Adeline Pharma is U24200TS2016PTC172691. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Adeline Pharma is at She No – 2 7 – 2 – 1740 Fire Station Main Road, Sanathnagar, Hyderabad, Telangana, India – 500018.
The latest financial statements of Adeline Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 06 September 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Adeline Pharma is 19AAOCA3402D1ZZ, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 21AAOCA3402D1ZE (Odisha).
Adeline Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
Adeline Pharma has 2 deals on record (1 funding round, 1 acquisition), with disclosed funding of ₹16.5 Lakh; the latest was in June 2016.
The peers of Adeline Pharma by revenue are Tancom Electronics Private Limited, Getwell Medicare Solution Private Limited, Pharmapoint (India) Private Limited, Workcell Solutions Private Limited, D Vijay Pharma Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).